2QLQ
| Crystal structure of SRC kinase domain with covalent inhibitor RL3 | 分子名称: | (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide, Proto-oncogene tyrosine-protein kinase Src | 著者 | Michalczyk, A, Rode, H.B, Gruetter, C, Rauh, D. | 登録日 | 2007-07-13 | 公開日 | 2008-03-11 | 最終更新日 | 2021-10-20 | 実験手法 | X-RAY DIFFRACTION (2.33 Å) | 主引用文献 | Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR. Bioorg.Med.Chem., 16, 2008
|
|
2QI8
| Crystal structure of drug resistant SRC kinase domain | 分子名称: | GLYCEROL, Proto-oncogene tyrosine-protein kinase Src | 著者 | Michalczyk, A, Rode, H.B, Gruetter, C, Rauh, D. | 登録日 | 2007-07-03 | 公開日 | 2008-03-18 | 最終更新日 | 2024-02-21 | 実験手法 | X-RAY DIFFRACTION (2.32 Å) | 主引用文献 | Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR. Bioorg.Med.Chem., 16, 2008
|
|
2QQ7
| Crystal structure of drug resistant SRC kinase domain with irreversible inhibitor | 分子名称: | (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide, Proto-oncogene tyrosine-protein kinase Src | 著者 | Michalczyk, A, Rode, H.B, Gruetter, C, Rauh, D. | 登録日 | 2007-07-26 | 公開日 | 2008-03-11 | 最終更新日 | 2021-10-20 | 実験手法 | X-RAY DIFFRACTION (2.38 Å) | 主引用文献 | Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR. Bioorg.Med.Chem., 16, 2008
|
|